Showing results (311-320 of 369) with videos related to

Sort By:
Pageof 37
Plos One|May 15, 2008
Expression of aquaporin 5 (AQP5) promotes tumor invasion in human non small cell lung cancerYoung Kwang Chae, Janghee Woo, Mi-Jung Kim, et al.
Esophagus : Official Journal of the Japan Esophageal Society|June 2, 2026
Optimizing lymph node dissection for accurate nodal staging in early-stage esophageal squamous cell carcinoma: a multicenter studySeong Yong Park, Boram Park, Jae Kwang Yun, et al.
Theriogenology|April 29, 2019
GDNF family receptor alpha 1 is a reliable marker of undifferentiated germ cells in bullsYong-Hee Kim, Yu-Ri Choi, Bang-Jin Kim, et al.
JTCVS Open|July 10, 2023
Asia expert consensus on segmentectomy in non-small cell lung cancer: A modified Delphi studyLunxu Liu, Keiju Aokage, Chang Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2007
A mutation in a chromosome condensin II subunit, kleisin beta, specifically disrupts T cell developmentKatharine M Gosling, Lydia E Makaroff, Angelo Theodoratos, et al.
Gastroenterology Report|July 8, 2024
Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinomaYoung Seob Shin, Jeong Yun Jang, Ye Jin Yoo, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2015
Randomized phase 2 trial of S1 and oxaliplatin-based chemoradiotherapy with or without induction chemotherapy for esophageal cancerDok Hyun Yoon, Geundoo Jang, Jong Hoon Kim, et al.
International Journal of Molecular Medicine|May 16, 2015
Effects of paracrine factors on CD24 expression and neural differentiation of male germline stem cellsBang-Jin Kim, Yong-An Lee, Ki-Jung Kim, et al.
Nuclear Medicine and Molecular Imaging|June 6, 2014
The Feasibility of (18)F-Fluorothymidine PET for Prediction of Tumor Response after Induction Chemotherapy Followed by Chemoradiotherapy with S-1/Oxaliplatin in Patients with Resectable Esophageal CancerSeol Hoon Park, Jin-Sook Ryu, Seung-Jun Oh, et al.
Japanese Journal of Clinical Oncology|October 24, 2007
Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancerSung Sook Lee, Sung-Bae Kim, Seung-Il Park, et al.
Pageof 37